Kathryn Lang, MBBS, MRCP (UK), FRCPath, is Senior Vice President, Real-World Data and Analytics at Freenome.
Kathryn joined Freenome from Guardant Health, where she served as Vice President of Outcomes and Evidence. In this role, she was responsible for primary and secondary research in early cancer detection as well as health economics modeling and real-world data. Kathryn also served as the Global Head of Oncology Real-World Evidence for Pfizer.
Kathryn is an experienced hematologist-oncologist with training in epidemiology and data science from Newcastle University and the Erasmus Medical Center, Rotterdam. Kathryn spent ten years in academic medicine at King’s College Hospital, London, specializing in hematological malignancy and real-world, observational evidence generation.